Live Breaking News & Updates on Accompanying Electrolyte

Stay updated with breaking news from Accompanying electrolyte. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Lilly Announces Details of Presentations at 2021 American Society of Clinical Oncology (ASCO) Annual Meeting


Lilly Announces Details of Presentations at 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
News provided by
Share this article
Share this article
INDIANAPOLIS, May 19, 2021 /PRNewswire/ New data from across Eli Lilly and Company s (NYSE: LLY) oncology portfolio will be presented at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting, held June 4-8, 2021. The data include new analyses of Verzenio
® (abemaciclib) from the Phase 3 monarchE trial in patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) early breast cancer (EBC) with a high risk of recurrence who received neoadjuvant chemotherapy. In addition, the first clinical data from the Phase 1 study of Lilly s oral selective estrogen receptor degrader (SERD) will be presented at the meeting. ....

United States , Fabrice Andre , Fulvestrant Faslodex , Shao Zhimin , Torres Raquel , Eli Lilly , Deboras Bruno , Douglas Yee , Kevin Hern , Kristinm Sheffield , Medimmune Astrazeneca , Wambul Gathirua Mwangi , Josephm Llovet , Lauren Cohen , Courtney Kasinger , Komal Jhaveri , Wambui Gathirua Mwangi , Steven Attia , Monaliben Patel , Daniel Morgenstern , Neeraj Agarwal , Miguel Martin , Lorij Wirth , American Society Of Clinical Oncology , Lilly United States , Exchange Commission ,